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ABSTRACT
Objective: A simple, novel, sensitive, rapid high-performance liquid chromatographic (RP-HPLC) method has been developed and validated for 
quantitative determination of atomoxetine HCl (ATH) in bulk and formulations.
Methods: The chromatographic development was carried out on RP-HPLC. The column used as Xterra RP 18 (250 mm × 4.6 mm, 5 µ particle size), 
with mobile phase consisting of methanol: water 80:20 V/V. The flow rate was 1.0 mL/min and the effluents were monitored at 270 nm.
Results: The retention time was found to be 5.350 min. The method was validated as per International Conference on Harmonization Guideline with 
respect to linearity, accuracy, precision, and robustness. The calibration curve was found to be linear over a range of 2–10 μg/mL with a regression 
coefficient of 0.9999. The method has proved high sensitivity and specificity.
Conclusion: The results of the study showed that the proposed RP-HPLC method was simple, rapid, precise and accurate which is useful for the 
routine determination of ATH in bulk drug and in its pharmaceutical dosage form.
Keywords: Atomoxetine hydrochloride, Capsules, Rapid high-performance liquid chromatographic, Validation.
INTRODUCTION
The atomoxetine HCl (ATH) (Fig. 1) is the first non-stimulant drug 
approved by the United States FDA for symptomatic treatment of 
attention-deficit hyperactivity disorder and selective noradrenaline 
(norepinephrine) reuptake inhibitor [1,2]. Chemically, it is (R)-N-
methyl-3-(o-tolyloxy)-3-phenylpropylamine hydrochloride [3,4]. 
Its molecular formula is C17H21NO. HCl and its molecular weight are 
291.82 g/mol. Atomoxetine, principally it is metabolized by CYP4502D6 
through oxidative enzymatic pathway and by glucuronidation [5]. The 
literature survey shows that several analytical techniques such as high-
performance liquid chromatographic (HPLC) [6-11], LC-MS-MS [12], 
HPTLC [13], chemiluminescence [14], and UV [15,16] have been 
reported for its determination of ATH in plasma and capsule dosage 
forms. The validation of analytical procedure used for different type 
of synthetic and natural substance [17-19]. The present work reports 
simple, rapid, sensitive and economical rapid HPLC (RP-HPLC) method 
with UV detection, useful for the routine analysis of ATH in bulk and 
pharmaceutical formulations. The method parameters such as linearity, 
accuracy, precision, robustness, stability, and system suitability 
validated as per International Conference on Harmonization (ICH) 
guidelines and USP guidelines [20,21].
METHODS
The ATH pure standard was supplied by TCI Chemicals Pvt. Ltd. Chennai, 
India. Faint 10 mg capsules (Sun Pharmacy, Chennai), labeled to contain 
10 mg ATH, were obtained from the market. Analytical reagent grade 
chemicals were procured from Company Merck Specialties Pvt. Ltd. 
(Mumbai, India). The column used as Xterra RP 18 (250 mm × 4.6 mm, 
5 µ particle size) for the study.
Instrumentation, chromatographic conditions
HPLC analysis was carried out on Xterra RP 18 (250 mm × 4.6 mm, 5 µ 
particle size), reversed phase column. The mobile phase consisting 
of methanol: water 80:20 V/V. The flow rate of mobile phase was 
1 mL/min. The detection was carried out by at 270 nm. All analysis was 
carried out at a temperature of 30°C under isocratic conditions.
Preparation of standard solutions
Accurately weigh and transfer 10 mg of working standard into a 10 mL 
clean dry volumetric flask add about 10 mL of HPLC-grade water and 
sonicate to dissolve it completely and make volume up to the mark with 
the same solvent (stock solution). Further dilution is made and finally 
prepared 10 µg/mL of solution.
Selection of detection wavelength
ATH showed significant absorbance at 270 nm using UV–visible 
spectrophotometer.
Preparation of sample solutions
Accurately weigh and transfer 25 capsules (equivalent to 10 mg) 
into 50 mL volumetric flask add about 25 mL of HPLC grade water, 
sonicate for 15 min with occasional shaking. Cool the solution to room 
temperature and dilute to volume with HPLC grade water and mix. 
Further pipette 5 mL of the above solution into a 50 mL volumetric flask 
and dilute up to the mark with diluent.
Assay validation
The proposed RP-HPLC method was validated as per the guidelines of 
the ([ICH] Q2 [Rl]) for various parameters.
Linearity and range
The standard solution of ATH was applied in the concentration of 
2–10 µg/mL of ATH to evaluate linearity. The graph of peak area 
versus concentration was plotted. Least square linear regression 
analysis was done. The correlation coefficient, intercept, and slope 
were calculated.
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Sensitivity
Limit of detection (LOD) and limit of quantitation (LOQ) were calculated 
using formula 3.3 σ/S and 10 σ/S, respectively, where σ is the standard 
deviation of the response (y-intercept) and S is the slope of the linearity plot.
Specificity
The specificity of the method was determined by comparing test results 
obtained from analysis of sample solution containing excipients with 
that of test results those obtained from standard drug.
Precision studies
Precision was calculated by intra- and inter-day precision studies 
6 µg/mL concentration of ATH sample was analyzed six times on the 
similar day to find out any differences in the results. Interday precision 
study was done on three successive days.
Accuracy studies
Accuracy is the closeness in agreement between the accepted true value 
or a reference value and the actual results obtained. Accuracy studies 
are usually evaluated by determining the recovery of a spiked sample of 
the analyte into the mixture of the sample to be analyzed. For accuracy 
studies, I have used three different concentration of solution such as 
4 µg/mL, 6 µg/mL, and 8 µg/mL. For these, each concentration was 
injected and the mean % recovery was calculated.
Robustness studies
The effect of small but deliberate variations in method parameters such 
as flow rate, composition of the mobile phase, and wavelength was 
evaluated in this study. 2–10 µg/mL concentration of ATH was used in 
six replicates to study robustness of the method. The standard deviation 
of peak areas and % relative standard deviation (RSD) was determined.
RESULTS AND DISCUSSION
Chromatographic development
Chromatographic analysis was developed using a Xterra RP 18 (250 mm 
× 4.6 mm, 5 µ particle size) column. The mobile phase consists of 
methanol: water (80: 20 v/v) and that was supplied at a flow rate of 
1.0 mL/min. The mobile phase was degassed and filtered through 
0.45 μ filter under vacuum before pumping into HPLC system. The 
effluent was monitored by UV detection at 270 nm. Fig. 2 shows the 
optimized chromatogram of ATH.
Validation of the method
Linearity
The analyte response was linear (r2=0.9999) over the concentration 
range of 2–10 µg/mL of ATH. The results were shown in Table 1 and 
Fig. 3 shows the calibration curve. The curve shows the selected 
concentration gives acceptable accuracy and precision over a wide 
concentration range. The results demonstrate that an excellent 
correlation coefficient between the absorbance and concentration of 
ATH drug substance.
Sensitivity
The LOD was found to be 0.0001 µg for ATH. The LOQ for ATH was 
found to be 0.0005 µg representing good sensitivity of the method.
Specificity
The chromatograms obtained from standard and sample solutions are 
not interfering. It proves method is highly selective.
Precision
Intra- and inter-day variation in estimation of ATH (Table 2) showed 
that the % RSD was <2% during the analysis. These low values of RSD 
show that the precision of the method is good.
Accuracy
The study of accuracy reveals influences of additives that are usually 
present in the dosage forms on the quantitative parameters. The 
recovery study data presented in Table 3 indicates that the accuracy of 
the quantification of ATH was more than 98%, which indicate that the 
proposed simultaneous RP-HPLC method is reliable for the estimation 
of in the marketed formulation used in the study.
Robustness studies
The % RSD of peak areas was calculated for each parameter and was 
found to be <2% [Table 4].
Fig. 1: Chemical structure of atomoxetine HCl
Fig. 2: Optimized chromatograms of atomoxetine
Fig. 3: Linearity graph of atomoxetine HCl by rapid high-
performance liquid chromatographic
Table 1: Linear regression analysis of ATH
Parameters Values
Linearity range (µg/mL) 2–10
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Analysis of a marketed preparation
The results obtained for the amount of ATH in capsules as against the label 
claims were in good agreement signifying that there is no interference from 
any of the excipients presents in capsules. The percent assay was found to be 
99.93%, for ATH, in marketed formulation in six replicate determinations.
CONCLUSION
The purpose of this investigation was to develop and validate a method 
using a simple, rapid, sensitive, precise, and accurate RP-HPLC for the 
routine determination of ATH in bulk and pharmaceutical preparations. 
The proposed method is suitable for the pharmaceutical analysis in 
various analytical laboratories. The retention time and run time were 
very short, hence, requires less mobile phase for this method, making 
it more economical and rapid. Hence, this method can be used for the 
analysis of large number of samples.
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Table 2: Intraday- and inter-day precision studies of ATH







6 µg 99.63/99.71 0.771/1.088
ATH: Atomoxetine HCl










6 4 10.01 3.99 0.31
6 6 11.97 6.13 0.19
6 8 14.22 7.91 0.12
*Average of three determination
Table 4: Robustness studies of ATH
Parameter Parameter varied %RSD










Wavelength in nm 268
270
272
0.74
ATH: Atomoxetine HCl
